Tylosin resistance-conferring gene, designated tlrc, for use in streptomycesfradiae
CA 1286240 C · Owner: Eli Lilly And Company · Inventors: Birmingham, Virginia A.; Cox, Karen L.; Seno, Eugene T.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The tlrC gene is a novel tylosin resistanceconferring gene isolated from Streptomyces fradiae and used to construct a number of cloning vectors for use in Streptomyces. One such cloning vector, plasmid pSKC10 can be obtained in S. fradiae JS87 under the accession number NRRL 18072. S. fradiae JS87 is the preferred host when the tlrC gene is used to select tylosinresistant Streptomyces transformants.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted July 16, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 16, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.